Table 1.
The relationship between ALI and clinicopathological characteristics
| Cases (n, %) |
ALI <18 (n, %) |
ALI ≥18 (n, %) |
P-value | |
|---|---|---|---|---|
| Age (years) | 0.483 | |||
| ≤60 | 161 (54.9) | 63 (52.5) | 98 (56.6) | |
| >60 | 132 (45.1) | 57 (47.5) | 75 (43.4) | |
| Sex | 0.475 | |||
| Female | 34 (11.6) | 12 (10.0) | 22 (12.7) | |
| Male | 259 (88.4) | 108 (90.0) | 151 (87.3) | |
| Tumor length (cm) | 0.028 | |||
| ≤3 | 76 (25.9) | 23 (19.2) | 53 (30.6) | |
| >3 | 217 (74.1) | 97 (80.8) | 120 (69.4) | |
| Tumor location | 0.304 | |||
| Upper | 16 (5.5) | 5 (4.2) | 11 (6.4) | |
| Middle | 143 (48.8) | 54 (45.0) | 89 (51.4) | |
| Lower | 134 (45.7) | 61 (50.8) | 73 (42.2) | |
| Differentiation | 0.010 | |||
| Well | 43 (14.7) | 11 (9.2) | 32 (18.5) | |
| Moderate | 188 (64.2) | 75 (62.5) | 113 (65.3) | |
| Poor | 62 (21.1) | 34 (28.3) | 28 (16.2) | |
| Vessel involvement | 0.808 | |||
| Negative | 246 (84.0) | 100 (83.3) | 146 (84.4) | |
| Positive | 47 (16.0) | 20 (16.7) | 27 (15.6) | |
| Depth invasion | 0.009 | |||
| T1 | 49 (16.7) | 13 (10.8) | 36 (20.8) | |
| T2 | 46 (15.7) | 17 (14.2) | 29 (16.8) | |
| T3 | 163 (55.6) | 68 (56.7) | 95 (54.9) | |
| T4a | 35 (12.0) | 22 (18.3) | 13 (7.5) | |
| Nodal metastasis | 0.004 | |||
| Negative | 149 (50.9) | 49 (40.8) | 100 (57.8) | |
| Positive | 144 (49.1) | 71 (59.2) | 73 (42.2) | |
| Adjuvant therapy | 0.010 | |||
| No | 196 (66.9) | 70 (58.3) | 127 (73.4) | |
| Yes | 97 (33.1) | 50 (41.7) | 47 (26.6) |
Note: Statistically significant P-values are shown in bold.
Abbreviation: ALI, advanced lung cancer inflammation index.